(3S,4S)-(4R)-4,5-DIHYDROXY-1-(4-(5-(4-(PENTYLOXY)PHENYL)-3-ISOXAZOLYL)BENZOYL)-L-PROLYL-L-THREONYL-(4R)-4-HYDROXY-L-PROLYL-(4S)-4-HYDROXY-4-(4-HYDROXY-3-(SULFOOXY)PHENYL)-L-THREONYL-(3R)-3-HYDROXY-L-GLUTAMINYL-3-HYDROXY-4-METHYL-L-PROLINAMIDE
UNII TSF8WBZ4Q8
Substance Identification & Data
This profile provides standardized clinical and technical data for (3s,4s)-(4r)-4,5-dihydroxy-1-(4-(5-(4-(pentyloxy)phenyl)-3-isoxazolyl)benzoyl)-l-prolyl-l-threonyl-(4r)-4-hydroxy-l-prolyl-(4s)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-l-threonyl-(3r)-3-hydroxy-l-glutaminyl-3-hydroxy-4-methyl-l-prolinamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TSF8WBZ4Q8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 708973-42-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C56H71N9O23S WZWVIDKXMZNASD-AXGCAYCJSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (3s,4s)-(4r)-4,5-dihydroxy-1-(4-(5-(4-(pentyloxy)phenyl)-3-isoxazolyl)benzoyl)-l-prolyl-l-threonyl-(4r)-4-hydroxy-l-prolyl-(4s)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-l-threonyl-(3r)-3-hydroxy-l-glutaminyl-3-hydroxy-4-methyl-l-prolinamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.